NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Estimated value
£1.2bn
Awarded value
£905.2m
Awarded 19 Dec 2024
Suppliers
1
Lots
1
1 awarded
Published
20 Jan 2025
Deadline 13 Sept 2024
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin Offer reference number: CM/PHS/23/5703 The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Scope
- Reference
- CF-2806900D0O000000rwimUAA
- Total value
- £1,200,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2025 to 31 Dec 2027
- CPV classifications
- 33651520
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 13 Sept 2024, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£905.2m
Award date
19 Dec 2024
Contract start
31 Mar 2025
Contract end
31 Dec 2027